Cardiac markers for risk stratification and prognosis in elderly patients with HFpEF. [PDF]
Abusedera O +3 more
europepmc +1 more source
Prognostic Value of Baseline and Soluble ST2 Change in Patients With Light Chain Cardiac Amyloidosis. [PDF]
Xin A +10 more
europepmc +1 more source
The prognostic value of circulating soluble ST2 in patients with chronic heart failure. [PDF]
Zhang Y +5 more
europepmc +1 more source
sST2 as a Promising Cardiac Biomarker After Ischemic Stroke With Elevated Systolic Blood Pressure. [PDF]
Tu Y +9 more
europepmc +1 more source
Au-g-C<sub>3</sub>N<sub>4</sub>@MIL-100/Pt@CuS-induced self-accelerated dual-quenching ECL-RET strategy for sensitive sST2 detection. [PDF]
He X +7 more
europepmc +1 more source
Association of NT-proBNP and sST2 with Diastolic Dysfunction in Cirrhotic Patients and Its Therapeutic Implications. [PDF]
Chiorescu RM +6 more
europepmc +1 more source
Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapy. [PDF]
Al-Sanabra OM +3 more
europepmc +1 more source
Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis. [PDF]
Fazzini L +10 more
europepmc +1 more source
Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-small Cell Lung Cancer. [PDF]
Akdeniz FT +4 more
europepmc +1 more source
Predictive value of dynamic changes in RvD1, sST2, and PIV levels for the prognosis of STEMI patients after PCI: a prospective study. [PDF]
Xu Y, Li L, Lin Z, Hu Y, Liu Y, Zhou T.
europepmc +1 more source

